Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase-Reference-Cited by-同舟云学术

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase

Published:2010-02 Issue:1 Volume:33 Page:51-60
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:J Inherit Metab Dis

Author:

Harmatz Paul,Yu Zi-Fan,Giugliani Roberto,Schwartz Ida Vanessa D.,Guffon Nathalie,Teles Elisa Leão,Miranda M. Clara Sá,Wraith J. Edmond,Beck Michael,Arash Laila,Scarpa Maurizio,Ketteridge David,Hopwood John J.,Plecko Barbara,Steiner Robert,Whitley Chester B,Kaplan Paige,Swiedler Stuart J.,Hardy Karen,Berger Kenneth I.,Decker Celeste

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

http://www.springerlink.com/index/pdf/10.1007/s10545-009-9007-8

Reference20 articles.

1. American Thoracic Society (1991) Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144(5):1202–1218

2. American Thoracic Society (1995) Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 152(3):1107–1136

3. Braun NM, Arora NS et al (1983) Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax 38(8):616–623

4. Clarke LA, Wraith JE et al (2009) Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics 123(1):229–240

5. Engstroem H, Grimby G et al (1964) Dynamic spirometry in patients with tracheal stenosis. Acta Med Scand 176:329–334

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developmental and Inherited Liver Disease;MacSween's Pathology of the Liver;2024

2. Management of MPS-I using ERT: The Egyptian experience;2023-11-16

3. Hurler Syndrome (Mucopolysaccharidosis Type 1): A Case Report;Cureus;2023-04-18

4. Liver-Directed Adeno-Associated Virus–Mediated Gene Therapy for Mucopolysaccharidosis Type VI;NEJM Evidence;2022-06-28

5. Chest wall volumes, diaphragmatic mobility, and functional capacity in patients with mucopolysaccharidoses;Disability and Rehabilitation;2022-06-13